Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Government cash injection for University spin-out company’s stem cell research

25.01.2005


A spin-out company from the University of Nottingham has been awarded around £250,000 of Government funding to develop innovative stem cell therapies that could one day provide new treatments for patients suffering from illnesses including Parkinson’s disease and stroke.

RegenTec, a company at the cutting-edge of regenerative medicine that specialises in the development of stem cell and tissue engineering technology, is a partner in two projects that have attracted a total of £3.7 million from the Department of Trade and Industry’s Technology Programme.

The first award, made to a five-partner consortium led by the company ReNeuron, will bring together science and industry experts to develop new stem cell products for commercial use in treating neurodegenerative diseases such as stroke, Huntington’s disease and Parkinson’s disease, as well as other illnesses including diabetes, blindness and cardiac disease.



RegenTec will be working on the development of delivery systems that provide a supportive environment for stem cells. Once administered, the stem cells either encourage the growth of tissue by triggering the body’s own repair processes or themselves begin to grow and form new tissue.

The second project, led by the company NovaThera, will aim to develop our understanding of the way in which cells grow and develop into specific cells for different functions. The research, which will initially focus on cells to repair bone, lung and liver tissue, will look at ways in which this growth can be effectively controlled or manipulated.

RegenTec specialises in the development of a range of materials that can be injected to deliver cells directly to the area of the body where they are needed. The materials are designed to solidify upon injection to create templates for tissue repair known as scaffolds. The scaffolds aim to enhance the survival and function of the stem cells and provide a controlled environment that encourages the cells to grow. Research will also be carried out into ways of taking scarce stem cells and growing a larger supply for use in treating a range of patients and diseases.

RegenTec, which is based at BioCity, Nottingham’s groundbreaking new healthcare and bioscience innovation centre, was set up four years ago by The University of Nottingham’s Professor Kevin Shakesheff.

Welcoming the DTI grant funding, Professor Shakesheff said: "Stem cell technology could revolutionise the treatment of life-threatening or long-term diseases. These awards confirm RegenTec’s position as a key partner in advancing regenerative medicine from The University of Nottingham’s world-class research labs through to patient treatments.

"I’m delighted that the partnership between the University and RegenTec is again generating biotech jobs at BioCity Nottingham."

Emma Thorne | alfa
Further information:
http://www.nottingham.ac.uk

More articles from Life Sciences:

nachricht Fingerprint' technique spots frog populations at risk from pollution
27.03.2017 | Lancaster University

nachricht Parallel computation provides deeper insight into brain function
27.03.2017 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>